Your browser doesn't support javascript.
loading
The Evolution of Hemophilia Therapeutics: An Illustrated Review.
Español, María G; Mistretta, Jessica N; Tarantino, Michael D; Roberts, Jonathan C.
Affiliation
  • Español MG; The Bleeding & Clotting Disorders Institute, Peoria, IL.
  • Mistretta JN; Department of Pediatrics, University of Illinois College of Medicine at Peoria, Peoria, IL.
  • Tarantino MD; The Bleeding & Clotting Disorders Institute, Peoria, IL.
  • Roberts JC; The Bleeding & Clotting Disorders Institute, Peoria, IL.
Res Pract Thromb Haemost ; 8(3): 102308, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38883215
ABSTRACT
Hemophilia is a rare genetic bleeding disorder historically associated with high morbidity and mortality. Some individuals with hemophilia suffer associated chronic joint disease, chronic pain, and other physical and mental health challenges. In the last 50 years, a better understanding of the pathophysiology of the disease has resulted in extraordinary therapeutic advances leading to enhanced quality of life and increased life expectancy. We present an illustrated review of the evolution of hemophilia treatment from the development of non-factor therapies to gene therapy.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Res Pract Thromb Haemost Year: 2024 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Res Pract Thromb Haemost Year: 2024 Document type: Article Country of publication: United States